每年專案
個人檔案
經歷
- 2020 臺北醫學大學醫務管理學系教授
- 2016 臺北醫學大學醫務管理學系副教授
指紋
查看啟用 Wei Pin Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 10 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Increased short- and long-term risk of sleep disorders in people with traumatic brain injury
Wang, Y. J., Chang, W. C., Wu, C. C., Chiang, Y. H., Chiu, W. T., Chen, K. Y. & Chang, W. P., 2021, 於: Neuropsychological Rehabilitation. 31, 2, p. 211-230 20 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
1 引文 斯高帕斯（Scopus） -
Prognostic effect of comorbid disease and immune gene expression on mortality in kidney cancer—a population based study
Wong, C. S., Chen, T. T., Chang, W. P., Wong, H. S. C., Wu, M. Y., Adikusuma, W., Lin, Y. F. & Chang, W. C., 六月 2020, 於: Cancers. 12, 6, p. 1-13 13 p., 1654.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
公共衛生護理人員工作壓力、主管支持與工作滿意之相關性
張偉斌(Wei-Pin C, 何政勳(Cheng-Hsun H, 溫信財(Hsyien-Chia W & 林玉珊(Yu-Shan L, 2020, 於: 北市醫學雜誌. 17, 4, p. 412-424 13 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
An Assessment of the Interoperability of Electronic Health Record Exchanges Among Hospitals and Clinics in Taiwan
Wen, H-C., Chang, W-P., Hsu, M-H., Ho, C-H. & Chu, C. M., 三月 28 2019, 於: JMIR medical informatics. 7, 1, p. e12630研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Revisiting HERQL, the hernia-specific quality-of-life assessment instrument, to extend the clinical applicability for abdominal wall hernias
Huang, C-C., Lien, H-H., Wong, J-U., Ho, T-F., Chang, W-P. & Hunag, C-S., 十一月 28 2019, 於: Hernia.研究成果: 雜誌貢獻 › 文章 › 同行評審
資料集
-
Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y. (Contributor), Li, W. (Contributor), Chang, Y. (Contributor), Peng, C. (Contributor), Cheng, C. (Contributor), Chang, W. P. (Contributor) & Chuang, C. (Contributor), Unknown Publisher, 一月 1 2016
DOI: 10.6084/m9.figshare.c.3642380_d1.v1, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/4462352/1
資料集: Dataset
-
Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y. (Contributor), Li, W. (Contributor), Chang, Y. (Contributor), Peng, C. (Contributor), Cheng, C. (Contributor), Chang, W. P. (Contributor) & Chuang, C. (Contributor), Unknown Publisher, 一月 1 2016
DOI: 10.6084/m9.figshare.c.3642380.v1, https://figshare.com/collections/Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/3642380/1
資料集: Dataset